Investment analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Monday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE AMPE opened at $0.00 on Monday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The company has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.
About Ampio Pharmaceuticals
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- About the Markup Calculator
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- The 3 Best Retail Stocks to Shop for in August
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
